前列腺重复穿刺研究进展  

The research progress of repeat prostate biopsy

作　　者：胡林军 寿建忠 Hu Linjun;Shou Jianzhong(Department of Urology,Huanxing Cancer Hospital,Chaoyang District,Beijing 100122,China;Department of Urology,National Cancer Center/National Cancer Clinical Research Center/Cancer Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100006,China)

机构地区：[1]北京市朝阳区桓兴肿瘤医院泌尿外科,100122 [2]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院泌尿外科,北京100006

出　　处：《中华泌尿外科杂志》2021年第1期71-74,共4页Chinese Journal of Urology

基　　金：国家癌症中心攀登基金(NCC201801B001)。

摘　　要：前列腺穿刺存在漏诊前列腺癌的可能,重复穿刺有其必要性。本文对前列腺重复穿刺独立危险因素、穿刺途径选择和穿刺新技术进展方面进行综述,以提高临床医生对前列腺重复穿刺适应证的认识。对符合前列腺重复穿刺的患者,推荐使用mpMRI靶向穿刺,以提高有临床意义前列腺癌的检出率,减少无临床意义前列腺癌的检出率。Repeat prostate biopsy is of great significance for missed diagnosis of prostate cancer.We make a review on the independent risk factors,route selection and new techniques to improve clinicans’cognition of prostate biopsy indications.MpMRI targeted biopsy is recommended for patients who are eligibile for repeat biopsy for higher detection rate of clinically significant prostate cancer and lower rate of non-clinically significant prostate cancer.

关 键 词：前列腺肿瘤 重复穿刺 研究进展 

分 类 号：R737.25[医药卫生—肿瘤]